The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper Article (Web of Science)

International Collaboration

cited authors

  • Evans, Randolph W.; Tepper, Stewart J.; Shapiro, Robert E.; Sun-Edelstein, Christina; Tietjen, Gretchen E.

publication date

  • June 1, 2010


published in

author keyword

  • FDA alert
  • norepinephrine reuptake inhibitor
  • selective serotonin
  • selective serotonin reuptake inhibitor
  • serotonin syndrome
  • triptan


start page

  • 1089

end page

  • 1099


  • 50


  • 6